| 1. |
Deans, R. J. and Moseley, A. B. (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol.
28, 875–884.
|
| |
| 2. |
Bianco, P., Riminucci, M., Gronthos, S., and Robey, P. G. (2001) Bone marrow stromal stem cells: nature, biology, and potential
applications. Stem Cells
19, 180–192.
|
| |
| 3. |
Minguell, J. J., Erices, A., and Conget, P. (2001) Mesenchymal stem cells. Exp. Biol. Med.
226, 507–520.
|
| |
| 4. |
Castro-Malaspina, H., Gay, R. E., Resnick, G., et al. (1980) Characterization of human bone marrow fibroblast colony-forming
cells (CFU-F) and their progeny. Blood
56, 289–301.
|
| |
| 5. |
Friedenstein, A. J., Gorskaja, J. F., and Kulagina, N. N. (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic
organs. Exp. Hematol.
4, 267–274.
|
| |
| 6. |
Prockop, D. J. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science
276, 71–74.
|
| |
| 7. |
Conget, P. A. and Minguell, J. J. (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor
cells. J. Cell Physiol.
181, 67–73.
|
| |
| 8. |
Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999) Multilineage potential of adult human mesenchymal stem cells.
Science
284, 143–147.
|
| |
| 9. |
Gerson, S. L. (1999) Mesenchymal stem cells: no longer second class marrow citizens. Nat. Med.
5, 262–264.
|
| |
| 10. |
Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., et al. (2000) Adult bone marrow stromal cells differentiate into neural cells
in vitro. Exp. Neurol.
164, 247–256.
|
| |
| 11. |
Pereira, R. F., Halford, K. W., O’Hara, M. D., et al. (1995) Cultured adherent cells from marrow can serve as long-lasting
precursor cells for bone, cartilage, and lung in irradiated mice. Proc. Natl. Acad. Sci. USA
92, 4857–4861.
|
| |
| 12. |
Frolova-Jones, E. A., Ensser, A., Stevenson, A. J., Kinsey, S. E., and Meredith, D. M. (2000) Stable marker gene transfer
into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors. J. Hematother. Stem Cell Res.
9, 573–581.
|
| |
| 13. |
Conget, P. A. and Minguell, J. J. (2000) Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal
progenitor cells. Exp. Hematol.
28, 382–390.
|
| |
| 14. |
Ding, L., Lu, S., Batchu, R., III, R. S., and Munshi, N. (1999) Bone marrow stromal cells as a vehicle for gene transfer.
Gene Ther.
6, 1611–1616.
|
| |
| 15. |
Lee, K., Majumdar, M. K., Buyaner, D., Hendricks, J. K., Pittenger, M. F., and Mosca, J. D. (2001) Human mesenchymal stem
cells maintain transgene expression during expansion and differentiation. Mol. Ther.
3, 857–866.
|
| |
| 16. |
Allay, J. A., Dennis, J. E., Haynesworth, S. E., et al. (1997) LacZ and interleukin-3 expression in vivo after retroviral
transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum. Gene Ther.
8, 1417–1427.
|
| |
| 17. |
Marx, J. C., Allay, J. A., Persons, D. A., et al. (1999) High-efficiency transduction and long-term gene expression with a
murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells. Hum. Gene Ther.
10, 1163–1173.
|
| |
| 18. |
Jaalouk, D. E., Eliopoulos, N., Couture, C., Mader, S., and Galipeau, J. (2000) Glucocorticoid-inducible retrovector for regulated
transgene expression in genetically engineered bone marrow stromal cells. Hum. Gene Ther.
11, 1837–1849.
|
| |
| 19. |
Chuah, M. K., Brems, H., Vanslembrouck, V., Collen, D., and Vandendriessche, T. (1998) Bone marrow stromal cells as targets
for gene therapy of hemophilia A. Hum. Gene Ther.
9, 353–365.
|
| |
| 20. |
Chiang, G. G., Rubin, H. L., Cherington, V., et al. (1999) Bone marrow stromal cell-mediated gene therapy for hemophilia A:
in vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino
acid 1648. Hum. Gene Ther.
10, 61–76.
|
| |
| 21. |
Chuah, M. K., Van Damme, A., Zwinnen, H., et al. (2000) Long-term persistence of human bone marrow stromal cells transduced
with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated
immunodeficient mice. Hum. Gene Ther.
11, 729–738.
|
| |
| 22. |
Hurwitz, D. R., Kirchgesser, M., Merrill, W., et al. (1997) Systemic delivery of human growth hormone or human factor IX in
dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum. Gene Ther.
8, 137–156.
|
| |
| 23. |
Gordon, E. M., Skotzko, M., Kundu, R. K., et al. (1997) Capture and expansion of bone marrow-derived mesenchymal progenitor
cells with a transforming growth factor-beta1-von Willebrand’s factor fusion protein for retrovirus-mediated delivery of coagulation
factor IX. Hum. Gene Ther.
8, 1385–1394.
|
| |
| 24. |
Cherington, V., Chiang, G. G., McGrath, C. A., et al. (1998) Retroviral vector-modified bone marrow stromal cells secrete
biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs
after reinfusion. Hum. Gene Ther.
9, 1397–1407.
|
| |
| 25. |
Nolta, J. A., Hanley, M. B., and Kohn, D. B. (1994) Sustained human hematopoiesis in immunodeficient mice by cotransplantation
of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood
83, 3041–3051.
|
| |
| 26. |
Bolotin, E., Smogorzewska, M., Smith, S., Widmer, M., and Weinberg, K. (1996) Enhancement of thymopoiesis after bone marrow
transplant by in vivo interleukin-7. Blood
88, 1887–1894.
|
| |
| 27. |
Bartholomew, A., Patil, S., Mackay, A., et al. (2001) Baboon mesenchymal stem cells can be genetically modified to secrete
human erythropoietin in vivo. Hum. Gene Ther.
12, 1527–1541.
|
| |
| 28. |
Matzner, U., Harzer, K., Learish, R. D., Barranger, J. A., and Gieselmann, V. (2000) Long-term expression and transfer of
arylsulfatase A into brain of arylsulfatase A-deficient mice transplanted with bone marrow expressing the arylsulfatase A
cDNA from a retroviral vector. Gene Ther.
7, 1250–1257.
|
| |
| 29. |
Matzner, U., Schestag, F., Hartmann, D., et al. (2001) Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice,
using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells. Hum. Gene Ther.
12, 1021–1033.
|
| |
| 30. |
Schwarz, E. J., Alexander, G. M., Prockop, D. J., and Azizi, S. A. (1999) Multipotential marrow stromal cells transduced to
produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum. Gene Ther.
10, 2539–2549.
|
| |
| 31. |
Schwarz, E. J., Reger, R. L., Alexander, G. M., Class, R., Azizi, S. A., and Prockop, D. J. (2001) Rat marrow stromal cells
rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro. Gene Ther.
8, 1214–1223.
|
| |
| 32. |
Baxter, M. A., Wynn, R. F., Deakin, J. A., et al. (2002) Retrovirally mediated correction of bone marrow-derived mesenchymal
stem cells from patients with mucopolysaccharidosis type I. Blood
99, 1857–1859.
|
| |
| 33. |
Zhang, X.-Y., La Russa, V. F., Bao, L., Kolls, J., Schwarzenberger, P., and Reiser, J. (2002) Lentiviral vectors for sustained
transgene expression in human bone marrow-derived stromal cells. Mol. Ther.
5, 555–565.
|
| |
| 34. |
Cheng, L., Du, C., Murray, D., et al. (1997) A GFP reporter system to assess gene transfer and expression in human hematopoietic
progenitor cells. Gene Ther.
4, 1013–1022.
|
| |
| 35. |
Adachi, A., Gendelman, H. E., Koenig, S., et al. (1986) Production of acquired immunodeficiency syndrome-associated retrovirus
in human and nonhuman cells transfected with an infectious molecular clone. J. Virol.
59, 284–291.
|
| |
| 36. |
Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M., and Naldini, L. (2000) Gene transfer by lentiviral vectors is limited
by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet.
25, 217–222.
|
| |
| 37. |
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., and Charneau, P. (2000) HIV-1 genome nuclear import is mediated
by a central DNA flap. Cell
101, 173–185.
|
| |
| 38. |
Reiser, J. (2000) Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther.
7, 910–913.
|
| |
| 39. |
Reiser, J., Lai, Z., Zhang, X. Y., and Brady, R. O. (2000) Development of multigene and regulated lentivirus vectors. J. Virol.
74, 10,589–10,599.
|
| |
| 40. |
Soneoka, Y., Cannon, P. M., Ramsdale, E. E., et al. (1995) A transient three-plasmid expression system for the production
of high titer retroviral vectors. Nucleic Acids Res.
23, 628–633.
|
| |
| 41. |
Matz, M. V., Fradkov, A. F., Labas, Y. A., et al. (1999) Fluorescent proteins from nonbioluminescent Anthozoa species. Nat. Biotechnol.
17, 969–973.
|
| |
| 42. |
Deng, W., Obrocka, M., Fischer, I., and Prockop, D. J. (2001) In vitro differentiation of human marrow stromal cells into
early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem. Biophys. Res. Commun.
282, 148–152.
|
| |